Singapore legislation

Regulation 36

of Healthcare Services (General) Regulations 2021

Regulation 36

Communications with patients

Amended byS 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023

Subregulation 1

Amended byS 414/2023 wef 26/06/2023

A licensee must implement effective measures to ensure that every patient receives accurate, complete and timely information about the patient’s care and treatment.

Subregulation 2

Amended byS 414/2023 wef 26/06/2023

A licensee must establish and implement an appropriate system for obtaining the consent of a patient for any medical procedure that is carried out, or to be carried out, in the provision of the licensable healthcare service, and maintaining a proper record of the consent obtained.

Subregulation 3

Amended byS 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023S 414/2023 wef 26/06/2023

Where, in the provision of a licensable healthcare service by a licensee, a test is conducted (whether or not by the licensee) on a patient who is under the direct care of the licensee, the licensee must ensure all of the following:

(a)

the findings of the test are brought to the attention of the requestor without undue delay;

(b)

the requestor reviews the findings in a timely manner;

(c)

the patient is informed, without undue delay, of the findings that, in the professional opinion of the requestor, are clinically significant;

(d)

the requestor advises the patient, based on the findings and without undue delay, on the patient’s condition, prognosis and clinical management.

Subregulation 4

Amended byS 414/2023 wef 26/06/2023

In this regulation, “requestor”, in relation to a test conducted on a patient, means —

(a)

the medical practitioner, dentist or collaborative prescribing practitioner who ordered the test for the patient; and

(b)

any medical practitioner, dentist or collaborative prescribing practitioner designated by the person mentioned in sub-paragraph (a) to carry out any duty mentioned in paragraph (3)(a), (b), (c) or (d).